FDA recently issued a public health advisory about the possibility of serious side effects from Trasylol (aprotinin), a drug used to prevent perioperative blood loss in patients undergoing CABG surgery. The advisory was based on two recently published observational studies. One reported that Trasylol may be associated with an increased risk of MI, stroke and renal [...]
Continue reading...27. July 2008
The anti depressent drug, Serzone, has been linked to wrongful death and severe liver damage in patients prescribed the drug. Children prescribed the drug may be linked to increased depression and suicide tendencies. The FDA has stated that the makers of Serzone, Bristol Myers Squibb, are responsible for the serious liver failures and liver problems linked [...]
Continue reading...27. July 2008
Recent studies have revealed that the heart medication drug, Plavix, has been link to adverse Plavix Side Effects. The study revealed that when taken with aspirin the drug may increase risk of strokes, heart attacks, intestinal bleeding, and death. Plavix was designed to prevent platelets from forming in the blood and reduce hemorrhage risks. One [...]
Continue reading...27. July 2008
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as: diarrhea that is watery or bloody; seizure (convulsions); confusion, hallucinations, unusual thoughts or behavior; dizziness, fainting, fast or pounding heartbeat; sudden [...]
Continue reading...27. July 2008
To ensure the safety of heparin products in the United States market, the FDA has asked companies that manufacture heparin-containing products to test the heparin active pharmaceutical ingredient (API) used in those products using capillary electrophoresis (CE) and the updated proton nuclear magnetic resonance (H-NMR) methods provided in the “Screening Methods” section of this website. [...]
Continue reading...27. July 2008
Medtronic, Inc. today announced that it is initiating a voluntary and precautionary recall of selected products featuring the Carmeda BioActive surface. The affected devices are disposable products used during cardiopulmonary bypass (CPB) for heart surgeries. Affected products include blood oxygenators, reservoirs, pumps, cannulae, and tubing packs. This action is being taken subsequent to the U.S. [...]
Continue reading...27. July 2008
The FDA was in the hot seat on Capitol Hill after a tainted drug was implicated in multiple deaths. A recent study found that more than 80 percent of active ingredients in U.S. drugs come from abroad, but only 11 percent of foreign suppliers are investigated by the FDA.
Continue reading...27. July 2008
The FDA has recently released a Class 1 Digitek recall for all strengths of Digitek tablets. The tablets, manufactured by Actavis Totowa, may possibly contain a double dose of the active ingredient in Digitek (digoxin). Over ingestion of digoxin can result in severe side effects including digitalis toxicity, a condition which may result in death. The [...]
Continue reading...27. July 2008
Avandia (rosiglitazone maleate) is a popular diabetes drug made by GlaxoSmithKline. A recent study by the FDA has lead to nationwide Avandia recall as the tablets have been shown to cause serious side effects including an increased risk of heart attack and cardiovascular diseases.
Continue reading...8. July 2008
Merck & Co., Inc. announced a voluntary withdrawal of Vioxx (rofecoxib) from the U.S. and worldwide market due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients on Vioxx. Vioxx is a prescription COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) that was approved by FDA in May 1999 [...]
Continue reading...
27. July 2008
0 Comments